Human α-Synuclein and MPTP Toxicity in Mice
Author Information
Author(s): Thomas Bobby, Mandir Allen S., West Neva, Liu Ying, Andrabi Shaida A., Stirling Wanda, Dawson Valina L., Dawson Ted M., Lee Michael K.
Primary Institution: Johns Hopkins University School of Medicine
Hypothesis
Does human α-synuclein expression affect the vulnerability of dopaminergic neurons to MPTP toxicity?
Conclusion
Human α-synuclein can replace mouse α-synuclein in terms of vulnerability to MPTP toxicity, but does not restore the developmental loss of dopaminergic neurons in α-synuclein null mice.
Supporting Evidence
- Increased expression of human α-synuclein does not increase vulnerability of dopaminergic neurons to MPTP.
- Human α-synuclein can restore MPTP-sensitivity in α-synuclein null mice.
- MPTP treatment resulted in significant reductions in TH-positive neurons in all mouse lines.
Takeaway
The study shows that human α-synuclein doesn't make mice more sensitive to a toxin that affects brain cells, but it can help protect some brain cells from damage.
Methodology
Transgenic mice were treated with MPTP and analyzed for neuronal counts and dopamine levels.
Limitations
The study primarily focuses on acute MPTP toxicity and may not reflect chronic effects.
Participant Demographics
Transgenic mice, specifically those expressing human α-synuclein variants.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website